Vadim Makarov - Concepedia

Author

Vadim Makarov

A N Bach Institute of Biochemistry ORCID

Also Known As

Makarov VA, Makarov, V.A., Makarov, Vadim, Makarov, Vadim A., Robinson, Andrew, Thierry Buclin, V A Makarov, V MAKAROV, V Makarov, V. A. MAKAROV

283

Publications

5.4K

Citations

H-Index

100

Concepts

All Affiliations

A N Bach Institute of Biochemistry École Polytechnique Fédérale de Lausanne University of Pavia Russian Academy of Sciences Comenius University Bratislava

About

Vadim Makarov is an author at A N Bach Institute of Biochemistry specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	2.8K
2	Natural Sciences	15	17	1.7K
3	Health Sciences	7	7	366
4	Engineering	5	5	301
5	Art History	1	1	24

Vadim Makarov

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Benzothiazinones Kill <i>Mycobacterium tuberculosis</i> by Blocking Arabinan Synthesis Vadim Makarov, Giulia Manina, Katarı́na Mikus̃ová, Science Bioorganic ChemistryMajor Btz TargetAntimicrobial ChemotherapyPharmaceutical ChemistryDrug Resistance	2009	722
Towards a new combination therapy for tuberculosis with next generation benzothiazinones Vadim Makarov, Benoît Lechartier, Ming Zhang, EMBO Molecular Medicine Pulmonary TuberculosisTuberculosis PreventionPharmacologyNew Combination TherapyPharmacological Agent	2014	379
Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-<scp>d</scp>-ribose 2′-epimerase DprE1 of <i>Mycobacterium tuberculosis</i> Claudia Jessen‐Trefzer, Rengifo-Gonzalez Monica, Marlon J. Hinner, Journal of the American Chemical Society Bioorganic ChemistryAntimicrobial ChemotherapyChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	2010	215
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-<scp>d</scp>-ribofuranose 2′-Oxidase DprE1 Claudia Jessen‐Trefzer, Henrieta Škovierová, Silvia Buroni, Journal of the American Chemical Society Bioorganic ChemistryBtz-resistant StrainsAntimicrobial ChemotherapyChemical BiologyPharmaceutical Chemistry	2011	175
Inhibition of Transfer to Secondary Receptors by Heparan Sulfate-Binding Drug or Antibody Induces Noninfectious Uptake of Human Papillomavirus Hans‐Christoph Selinka, Luise Florin, Hetal D. Patel, Journal of Virology	2007	174
2-Carboxyquinoxalines Kill <i>Mycobacterium tuberculosis</i> through Noncovalent Inhibition of DprE1 João Neres, Ruben C. Hartkoorn, Laurent R. Chiarelli, ACS Chemical Biology Tuberculosis PreventionBacteriologyMolecular BiologyAntimicrobial ChemotherapyDrug Resistance	2014	133
Nanofibers Made of Globular Proteins Yael Dror, Tamar Ziv, Vadim Makarov, Biomacromolecules Tissue EngineeringNanomedicineBsa SolutionNanofiberEngineering	2008	130
Clinical Isolates of <i>Mycobacterium tuberculosis</i> in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones Maria Rosalia Pasca, Giulia Degiacomi, Ana Ribeiro, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionPharmacotherapyClinical IsolatesDrug ResistanceMedicinal Chemistry	2010	92
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG Giorgia Mori, Laurent R. Chiarelli, Marta Esposito, Chemistry & Biology Medicinal ChemistryPulmonary TuberculosisBiochemistryM. TuberculosisMedicine	2015	87
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance Giulia Manina, Marco Bellinzoni, Maria Rosalia Pasca, Molecular Microbiology	2010	80

Page 1